CID 25031915

Lucitanib

Structural Information

Molecular Formula
C26H25N3O4
SMILES
CNC(=O)C1=CC=CC2=C1C=CC(=C2)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC
InChI
InChI=1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30)
InChIKey
CUDVHEFYRIWYQD-UHFFFAOYSA-N
Compound name
6-[7-[(1-aminocyclopropyl)methoxy]-6-methoxyquinolin-4-yl]oxy-N-methylnaphthalene-1-carboxamide
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

25
References

1958
Patents

443.1845 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 444.19178 205.8
[M+Na]+ 466.17372 215.2
[M-H]- 442.17722 215.7
[M+NH4]+ 461.21832 211.9
[M+K]+ 482.14766 209.8
[M+H-H2O]+ 426.18176 195.7
[M+HCOO]- 488.18270 226.5
[M+CH3COO]- 502.19835 214.5
[M+Na-2H]- 464.15917 211.4
[M]+ 443.18395 213.2
[M]- 443.18505 213.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe